P

Inventor

HOLOBOSKI MARK

US22 patents
⚠️ This page may combine multiple inventors who share the name “HOLOBOSKI MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALLERGAN INC

14 patents
US6710072B2Mar 23, 2004

Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

ALLERGAN INC118 citations98
US6956057B2Oct 18, 2005

EP4 agonists as agents for lowering intraocular pressure

ALLERGAN INC16 citations92
US6538018B1Mar 25, 2003

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure

ALLERGAN INC24 citations92
US6586462B2Jul 1, 2003

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

ALLERGAN INC16 citations84
US7022726B2Apr 4, 2006

ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

ALLERGAN INC4 citations73
US6767920B2Jul 27, 2004

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure

ALLERGAN INC6 citations73
US7872045B2Jan 18, 2011

Combination therapy for glaucoma treatment

ALLERGAN INC5 citations63
US7183324B2Feb 27, 2007

2,3,4-substituted cyclopentanones as therapeutic agents

ALLERGAN INC5 citations63
US7960378B2Jun 14, 2011

Therapeutic compounds

ALLERGAN INC4 citations60
US7514462B2Apr 7, 2009

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

ALLERGAN INC0 citations52
US7223746B2May 29, 2007

Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

ALLERGAN INC0 citations52
US7964634B2Jun 21, 2011

Therapeutic compounds

ALLERGAN INC0 citations51
US7612082B2Nov 3, 2009

Prostaglandin EP4 antagonists

ALLERGAN INC0 citations51
US9765065B2Sep 19, 2017

Therapeutic substituted cyclopentanes

ALLERGAN INC0 citations50

ALLERGAN SALES INC

5 patents

HOLOBOSKI MARK

2 patents

OLD DAVID W

1 patent